轻度退行性颈髓病非手术治疗转归:加拿大脊柱结局与研究网络观察性研究
1年内mJOA下降≥2分者占13.3%,平均3.4年手术转化率12.1%;转化者基线mJOA更低,未发现其他明确恶化或手术驱动因素。
要点
- 轻度DCM非手术治疗1年神经功能恶化(mJOA下降≥2分)率为13.3%。
- 平均3.4年手术转化率为12.1%,转化者基线mJOA更低。
- 未发现其他临床参数是神经恶化或手术转化的明确风险因素。
核心结论
- 保守治疗的轻度退行性颈髓病患者神经功能恶化或需手术相对少见。
- 1年恶化率13.3%,平均3.4年手术转化率12.1%,无明确风险因素。
- 转化手术者基线mJOA更低,延迟手术可改善颈部疼痛NRS。
研究设计与样本
- 评估基线及1年神经功能(mJOA)、患者报告结局(NDI、EQ-5D、SF-12、NRS)和影像学。
- 疾病进展定义为mJOA下降≥2分,手术转化作为次要终点。
主要发现
- 平均mJOA从基线16.8±0.8至1年16.5±1.3(P=.031),无临床显著变化。
- 1年EQ-5D改善、NRS手臂痛缓解,颈部疼痛低于最小临床重要差异水平。
- 13.3%(n=14)患者mJOA下降≥2分;17例(12.1%)平均3.4年转为手术。
- 手术转化者基线mJOA更低(16.2±1.0 vs 16.7±0.9;P=.03),基线患者报告结局无差异(P>.05)。
- 延迟手术改善颈部疼痛NRS(5.0±3.1 vs 1.9±1.4;P=.02)。
关键数值与推荐
- 轻度DCM定义:mJOA评分15–17分。
- 神经功能恶化定义:mJOA下降≥2分。
- 手术转化者基线mJOA更低(16.2±1.0 vs 16.7±0.9;P=.03)。
- 延迟手术后颈部疼痛NRS从5.0±3.1降至1.9±1.4(P=.02)。
临床怎么用
- 轻度DCM可先行非手术治疗,但需监测mJOA变化。
- 基线mJOA较低者更可能后续需要手术,应加强随访。
- 出现神经功能恶化或患者意愿时可考虑延迟手术,术后颈部疼痛可改善。
局限性
- 观察性研究设计,无法确立因果关系。
- 随访1年,手术转化平均时间3.4年,长期结局未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Degenerative cervical myelopathy (DCM) is the most common cause of spinal cord dysfunction in adults. The natural history of mild DCM is not fully understood, and both operative and nonoperative strategies have been proposed as treatment modalities. The aim of this study was to analyze the outcome of patients with mild DCM treated nonoperatively and identify risk factors for neurological deterioration and conversion to surgery. METHODS: All patients with mild DCM (modified Japanese Orthopaedic Association [mJOA] score 15-17), enrolled between 2015 and 2023, who were initially treated nonoperatively, as part of an ongoing prospective, multicenter observational cohort study were included. Neurological function (mJOA), patient-reported outcomes (neck disability index, EuroQol-5D, short form-12, numeric rating scale [NRS]), and radiographic findings at enrollment and 1 year were assessed. Progression of disease was defined as neurological deterioration by ≥2 mJOA. Conversion to surgery was a secondary end point. RESULTS: One hundred forty patients with mild DCM were initially treated nonoperatively. The mean mJOA score was 16.8 ± 0.8, with no clinically significant change after 1 year (16.5 ± 1.3; P = .031). Improved EuroQol-5D, relief in the NRS arm, and neck pain below the minimal clinically important difference level were noted after 1 year. A drop of ≥2 mJOA points occurred in 13.3% (n = 14). Seventeen patients (12.1%) crossed over to surgical treatment at an average time of 3.4 years. Patients who crossed over had lower baseline mJOA scores (16.2 ± 1.0 vs 16.7 ± 0.9; P = .03), but otherwise comparable patient-reported outcomes at baseline ( P > .05). Delayed surgery improved NRS neck pain (5.0 ± 3.1 vs 1.9 ± 1.4; P = .02). CONCLUSION: Neurological deterioration or the need for surgery is relatively uncommon in patients with conservatively treated mild DCM. A deterioration rate of 13.3% at 1 year and a conversion rate of 12.1% over 3.4 years with no clear risk factors were noted. Crossover patients presented with worse mJOA. No other clinically significant parameter was found to be a risk factor for neurological deterioration nor a driver for crossover.
引用
- Kögl N, Evaniew N, McIntosh G, et al. Outcome of Patients With Mild Degenerative Cervical Myelopathy Treated Nonoperatively: An Observational Study From the Canadian Spine Outcome and Research Network. Neurosurgery. 2025. PMID: 41090907. doi:10.1227/neu.0000000000003803
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。